This would have to be one of the safest, most reliable fish anaesthetic available. Hope it’ll become more freely available worldwide.
Begin forwarded message:
From: “Dr. David Scarfe”
Date: 29 May 2013 10:48:03 EDT
Subject: AquaVetMed e-News: Multi-country approval for fish anaesthetic, Tricaine Pharmaq
May 29, 2013
Marketing authorization for fish anaesthetic, Tricaine Pharmaq, in seven different countries
Press Release – In the past few months PHARMAQ has received national marketing authorisations for Tricaine Pharmaq for the United Kingdom, Ireland, Norway, Iceland, The Faroe Islands, Spain and Italy.
“Appropriate anaesthesia can provide benefits for a wide range of fish handling operations, helping to safeguard fish welfare and also improving operator safety during processes such as vaccination”, says Dr. Ben North, Managing Director of PHARMAQ Ltd.
Tricaine Pharmaq will replace the former product PHARMAQ MS 222, a compound well known to the industry and which held marketing authorisations in the UK and Ireland for many years. The formulation of the product remains the same (100% active tricaine methanesulphonate) and is available by prescription. Tricaine Pharmaq is readily soluble in water, making it safe and easy to use, with no requirement for solvents. Tricaine Pharmaq can benefit all sectors of the aquatic industry, from tranquilisation of ornamental fish during transport, through to full anaesthesia for surgical procedures, as well as anaesthesia of food fish at vaccination and egg collection from brood fish.
PHARMAQ UK will be the distribution centre for all of the different markets. Tricaine Pharmaq will be available in four different pack sizes from 25 g to 1000 g, all with separate national labels and inserts. “This is a great opportunity for PHARMAQ to introduce an established, safe and efficacious anaesthetic to support our customers in more of the markets where our fish vaccines are already being used”, added Dr. North
For further information, please contact:
Ben North Managing Director, PHARMAQ Ltd
Email ben.north@pharmaq.no
Tel: +44(0) 1425 651927
Mobile +44(0) 7900 195046
[For more information on this and other Pharmaq products, see http://www.pharmaq.no. ADS-Mod.]
___________________________
AquaVetMed e-News provides information to veterinary and veterinary-allied subscribers concerning aquatic animal medicine, health, welfare, public health and seafood safety, obtained from a variety of sources (largely AquaVetMed subscribers). While provided by the American Veterinary Medical Association’s, Aquatic Veterinary Medicine Committee and are for public distribution, they do not necessarily reflect the opinion of the AVMA or the veterinary profession. See the AVMA Terms of Use (http://tinyurl.com/29h2rf) for further information.
If e-News information is used elsewhere please acknowledge AquaVetMed as the source. Encourage individuals to subscribe rather than distribute through list serves.
Messages may contain attachments that will have been scanned for known viruses.
Subscription and Contributions: Interested veterinarians and veterinary-allied professionals can subscribe, unsubscribe, or contribute pertinent news or information, by sending a message with “For AquaVetMed -” and the topic in the subject line, to dscarfe@avma.org.
Note: Undelivered e-mails will not be resent; Subscribers will be deleted from the list after repeated undelivered or bounced messages and will have to re-subscribe.
Visit our website: http://www.avma.org
________________________________
